2
Announcements
Trials
Browse
Landscape
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Head & Neck
1
Gastrointestinal
1
Conditions
Thyroid Diseases
1
Parathyroid Diseases
1
Neurilemmoma
1
Neoplasms
1
Meningioma
1
Lung Neoplasms
1
Low Grade Glioma of Brain
1
Liver Neoplasms
1
Inflammatory Bowel Diseases
1
Inflammation
1
Glioma
1
Gastrointestinal Neoplasms
1
Colorectal Neoplasms
1
Brain Neoplasms
1
Interventions
Oxaliplatin
29
Fluorouracil
25
Leucovorin
20
Capecitabine
18
Irinotecan
17
Surveys and Questionnaires
16
Bevacizumab
14
Cisplatin
12
Blood Specimen Collection
11
Drug Therapy
10
Standard of Care
9
Nivolumab
9
Gemcitabine
9
Cetuximab
7
pembrolizumab
6
Specimen Handling
6
S 1 (combination)
6
Endoscopic Mucosal Resection
6
Cyclophosphamide
6
atezolizumab
5
Sunitinib
5
Radiotherapy
5
Folfox protocol
5
Educational Status
5
Docetaxel
5
fludarabine
4
aldesleukin
4
Radiosurgery
4
Pemetrexed
4
Magnetic Resonance Spectroscopy
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Gastrointestinal Neoplasms
×
Hyperspectral Imaging
×
Clear all
NCT04589884
2024-01-09
iEXMachyna3
IHU Strasbourg
Terminated
112 enrolled